Treace Medical (TMCI) Concepts announced the completion of the first cases utilizing SpeedPlate MicroQuad implants. The MicroQuad implant expands upon the broad utility of the SpeedPlate platform, which is designed for fast titanium compression fixation. The MicroQuad implant has a unique anatomic design with multiple points of fixation on each side of the joint to deliver dynamic compression with rotational stability through a one-inch incision for compatibility with minimally invasive techniques.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TMCI:
- Treace announces cases using RedPoint Intelliguide PSI with Adductoplasty
- Treace Medical announces Guy Guglielmino as chief commercial officer
- Treace Medical assumed with an Equal Weight at Morgan Stanley
- Treace Medical price target raised to $8 from $7 at Stifel
- Treace Medical Concepts Reports Strong Q3 2024 Growth